Lucintel forecasts that the TAVR, TMVR, and tissue heart valve segments in structural heart device market are expected to show above average growth during the forecast period and North America is expected to remain the largest market and is expected to witness the highest growth rate during the forecast period mainly due to increasing adoption of minimally invasive procedures for heart valve repair and replacement in this region.

1. The Global Structural Heart Device Market 2017-
2022: Trends, Forecast, and Opportunity Analysis
1

2. Industry Profiles Snapshot
Major Parameter Description
Market Segments by
Procedure
Repair (annuloplasty, valvuloplasty, transcatheter mitral Valves repair, other
repairs) and Replacement (surgical Valves ,Mechanical heart valves, tissue
heart valves and transcatheter aortic valves).
Market Segments by Position Aorta, mitral, and others.
Market Segments by Region North America, Europe, Asia Pacific and Rest of the World.
Top Companies Name
Edwards Lifesciences Corporation, Medtronic Public Limited Company, St.
Jude Medical, Inc., Boston Scientific Corporation, and LivaNova PLC
CAGR 14.3%
Key Industry Forecast
The global structural heart device market is expected to reach an estimated
$9.7 billion by 2022 and it is forecast to grow at a CAGR of 14.3% from 2017
to 2022.
Key Industry Driver
Driver: growing demand for minimally invasive surgery, growing healthcare
expenditure, and a growing geriatric population.
2

3. Industry Overview
Market Size
• The global structural heart device market is
expected to reach an estimated $9.7 billion
by 2022 and it is forecast to grow at a
CAGR of 14.3% from 2017 to 2022.
• Emerging trends which have a direct impact on
the dynamics of the structural heart device
industry include rising adoption of
transcatheter, aortic valve replacement
procedure and introduction of new hybrid
tissue engineered heart valve.
Market Size (2017) $9.7 billion
CAGR (2017-22) 14.3%
3
Industry Performance : Forecast